NET PROFIT (x1000 DKK)
EMPLOYEES
Faaborg Pharma A/S
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
2,244
|
2,034
|
2,020 |
| Total assets |
22,823
|
18,252
|
18,317 |
| Current assets |
17,231
|
11,963
|
11,115 |
| Current liabilities |
11,248
|
2,230
|
9,433 |
| Equity capital |
9,757
|
7,994
|
6,383 |
| - share capital |
1,000
|
1,000
|
1,000 |
| Employees (average) |
15
|
15
|
15 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
42.8%
|
43.8%
|
34.8% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
153.2%
|
536.5%
|
117.8% |
| Return on equity (ROE) |
23.0%
|
25.4%
|
31.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.